A detailed history of Pensionfund Sabic transactions in Abb Vie Inc. stock. As of the latest transaction made, Pensionfund Sabic holds 17,600 shares of ABBV stock, worth $4.12 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
17,600
Previous 17,700 0.56%
Holding current value
$4.12 Million
Previous $3.71 Million 8.41%
% of portfolio
1.09%
Previous 1.11%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 12, 2026

SELL
$211.96 - $244.38 $21,196 - $24,438
-100 Reduced 0.56%
17,600 $4.02 Million
Q1 2025

Jun 30, 2025

SELL
$169.2 - $216.66 $270,720 - $346,656
-1,600 Reduced 8.29%
17,700 $3.71 Million
Q4 2024

Jan 06, 2025

BUY
$164.99 - $203.87 $857,948 - $1.06 Million
5,200 Added 36.88%
19,300 $3.43 Million
Q3 2024

Oct 09, 2024

SELL
$163.84 - $199.33 $409,600 - $498,325
-2,500 Reduced 15.06%
14,100 $2.78 Million
Q1 2024

Apr 08, 2024

SELL
$159.82 - $182.1 $495,442 - $564,510
-3,100 Reduced 15.74%
16,600 $3.02 Million
Q1 2023

Apr 03, 2023

SELL
$144.61 - $166.54 $477,213 - $549,582
-3,300 Reduced 14.35%
19,700 $3.14 Million
Q2 2022

Jul 06, 2022

SELL
$137.62 - $174.96 $344,050 - $437,400
-2,500 Reduced 9.8%
23,000 $3.52 Million
Q1 2022

Apr 12, 2022

SELL
$131.98 - $163.75 $1.32 Million - $1.64 Million
-10,000 Reduced 28.17%
25,500 $4.13 Million
Q1 2021

Apr 01, 2021

SELL
$102.3 - $112.62 $511,500 - $563,100
-5,000 Reduced 12.35%
35,500 $3.84 Million
Q3 2020

Oct 05, 2020

BUY
$85.91 - $100.83 $343,640 - $403,320
4,000 Added 10.96%
40,500 $3.55 Million
Q2 2019

Jul 02, 2019

BUY
$65.7 - $83.98 $2.4 Million - $3.07 Million
36,500 New
36,500 $2.65 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pensionfund Sabic Portfolio

Follow Pensionfund Sabic and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pensionfund Sabic, based on Form 13F filings with the SEC.

News

Stay updated on Pensionfund Sabic with notifications on news.